Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1932)	11/7/2003 1:01:38 PM
From: tuck	of 3044

From Briefing.com: >>10:59AM Millennium Pharma: Near-term news flow should push shares higher -- BofA Sec (MLNM) 16.38 +0.21: Banc of America Sec believes that increasing near-term news flow with regard to Millennium's Velcadea nd MLN2704 will serve to push MLNM shares higher near-term. BofA notes that over the weekend an update on MLN2704 will be provided at an academic meeting; firm expects MLN2704, an antibody therapy for the treatment of prostate cancer, will demonstrate favorable clinical characteristics; firm notes that the compound has been off the radar screen for some time now. BofA reiterates its Buy rating and $24 tgt.<< Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next